These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 9287138)

  • 1. Purification, characterization and cloning of a novel variant of the superantigen Yersinia pseudotuberculosis-derived mitogen.
    Ramamurthy T; Yoshino K; Abe J; Ikeda N; Takeda T
    FEBS Lett; 1997 Aug; 413(1):174-6. PubMed ID: 9287138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA sequencing of the gene encoding a bacterial superantigen, Yersinia pseudotuberculosis-derived mitogen (YPM), and characterization of the gene product, cloned YPM.
    Miyoshi-Akiyama T; Abe A; Kato H; Kawahara K; Narimatsu H; Uchiyama T
    J Immunol; 1995 May; 154(10):5228-34. PubMed ID: 7730627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The superantigen gene ypm is located in an unstable chromosomal locus of Yersinia pseudotuberculosis.
    Carnoy C; Floquet S; Marceau M; Sebbane F; Haentjens-Herwegh S; Devalckenaere A; Simonet M
    J Bacteriol; 2002 Aug; 184(16):4489-99. PubMed ID: 12142419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Superantigen YPMa exacerbates the virulence of Yersinia pseudotuberculosis in mice.
    Carnoy C; Mullet C; Müller-Alouf H; Leteurtre E; Simonet M
    Infect Immun; 2000 May; 68(5):2553-9. PubMed ID: 10768943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification and characterization of a novel superantigen produced by a clinical isolate of Yersinia pseudotuberculosis.
    Yoshino K; Abe J; Murata H; Takao T; Kohsaka T; Shimonishi Y; Takeda T
    FEBS Lett; 1994 Dec; 356(1):141-4. PubMed ID: 7988709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequence analysis of the gene for a novel superantigen produced by Yersinia pseudotuberculosis and expression of the recombinant protein.
    Ito Y; Abe J; Yoshino K; Takeda T; Kohsaka T
    J Immunol; 1995 Jun; 154(11):5896-906. PubMed ID: 7751634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Yersinia pseudotuberculosis superantigens.
    Donadini R; Fields BA
    Chem Immunol Allergy; 2007; 93():77-91. PubMed ID: 17369701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal and solution structures of a superantigen from Yersinia pseudotuberculosis reveal a jelly-roll fold.
    Donadini R; Liew CW; Kwan AH; Mackay JP; Fields BA
    Structure; 2004 Jan; 12(1):145-56. PubMed ID: 14725774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification and gene cloning of a superantigen (YPM) produced by a patient strain of Yersinia pseudotuberculosis.
    Takeda T; Yoshino K; Itoh Y; Abe J; Shimonishi Y; Kohsaka T
    Contrib Microbiol Immunol; 1995; 13():331-3. PubMed ID: 8833866
    [No Abstract]   [Full Text] [Related]  

  • 10. Identification of the functional region on the superantigen Yersinia pseudotuberculosis-derived mitogen responsible for induction of lymphocyte proliferation by using synthetic peptides.
    Yoshino K; Takao T; Ishibashi M; Samejima Y; Shimonishi Y; Takeda T
    FEBS Lett; 1996 Jul; 390(2):196-8. PubMed ID: 8706858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Geographical heterogeneity between Far Eastern and Western countries in prevalence of the virulence plasmid, the superantigen Yersinia pseudotuberculosis-derived mitogen, and the high-pathogenicity island among Yersinia pseudotuberculosis strains.
    Fukushima H; Matsuda Y; Seki R; Tsubokura M; Takeda N; Shubin FN; Paik IK; Zheng XB
    J Clin Microbiol; 2001 Oct; 39(10):3541-7. PubMed ID: 11574570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Geographical heterogeneity between Far East and Europe in prevalence of ypm gene encoding the novel superantigen among Yersinia pseudotuberculosis strains.
    Yoshino K; Ramamurthy T; Nair GB; Fukushima H; Ohtomo Y; Takeda N; Kaneko S; Takeda T
    J Clin Microbiol; 1995 Dec; 33(12):3356-8. PubMed ID: 8586739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the superantigen-producing ability of Yersinia pseudotuberculosis strains of various serotypes isolated from patients with systemic or gastroenteric infections, wildlife animals and natural environments.
    Ueshiba H; Kato H; Miyoshi-Akiyama T; Tsubokura M; Nagano T; Kaneko S; Uchiyama T
    Zentralbl Bakteriol; 1998 Oct; 288(2):277-91. PubMed ID: 9809408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystallization and preliminary X-ray analysis of Yersinia pseudotuberculosis-derived mitogen.
    Donadini R; Wåhlberg M; Kohsaka T; Ito Y; Fields BA
    Acta Crystallogr D Biol Crystallogr; 2003 Jul; 59(Pt 7):1330-2. PubMed ID: 12832802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virulence characteristics of Yersinia pseudotuberculosis isolated from breeding monkeys in Japan.
    Iwata T; Une Y; Okatani AT; Kato Y; Nakadai A; Lee K; Watanabe M; Taniguchi T; Elhelaly AE; Hirota Y; Hayashidani H
    Vet Microbiol; 2008 Jun; 129(3-4):404-9. PubMed ID: 18242014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population structure and evolution of pathogenicity of Yersinia pseudotuberculosis.
    Ch'ng SL; Octavia S; Xia Q; Duong A; Tanaka MM; Fukushima H; Lan R
    Appl Environ Microbiol; 2011 Feb; 77(3):768-75. PubMed ID: 21131531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical role for a superantigen in Yersinia pseudotuberculosis infection.
    Abe J; Onimaru M; Matsumoto S; Noma S; Baba K; Ito Y; Kohsaka T; Takeda T
    J Clin Invest; 1997 Apr; 99(8):1823-30. PubMed ID: 9109426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Genotyping of Yersinia pseudotuberculosis isolated in Siberia and Far East].
    Chesnokova MV; Klimov VT; Maramovich AS
    Zh Mikrobiol Epidemiol Immunobiol; 2006; (6):20-5. PubMed ID: 17163133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Streptococcus dysgalactiae-derived mitogen (SDM), a novel bacterial superantigen: characterization of its biological activity and predicted tertiary structure.
    Miyoshi-Akiyama T; Zhao J; Kato H; Kikuchi K; Totsuka K; Kataoka Y; Katsumi M; Uchiyama T
    Mol Microbiol; 2003 Mar; 47(6):1589-99. PubMed ID: 12622814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification and partial characterization of a product from Yersinia pseudotuberculosis with the ability to activate human T cells.
    Miyoshi-Akiyama T; Imanishi K; Uchiyama T
    Infect Immun; 1993 Sep; 61(9):3922-7. PubMed ID: 8359914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.